Company intelligence / Profile preview

CSL Seqirus

Holly Springs, North Carolina, USAcslseqirus.us ↗

Ownership: Public · CSL
Employees: ~3000
Development stage: Commercial

Overview

CSL Seqirus is one of the world’s largest manufacturers of influenza vaccines with commercialized products distributed in over twenty countries. The company leverages egg-based, cell-culture–based, and adjuvanted technologies to offer a broad portfolio of seasonal and pandemic flu vaccines. Real-world evidence supports their effectiveness across age groups including high-risk populations such as older adults. In addition to flu vaccines, they supply antivenoms and Q fever vaccine primarily within Australia/New Zealand.

Therapeutic areas: OtherInfectious Diseases
Modalities: Inactivated influenza vaccines (egg-based and cell-based)Adjuvanted vaccinesRecombinant protein vaccines (limited pipeline)Antivenoms and specialty biologics in Australia/New Zealand
Industry: Pharma

Drug pipeline

132 assets

agriflu

Approved

131 more assets in the full pipeline.

Request access →

Partnerships

Collaborates with global public health agencies/governments on pandemic preparednesspartnerships with WHO/international health authorities for surveillance/vaccine strain selection.

Beyond the preview

Go deeper on CSL Seqirus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSL Seqirus.

Explore the full profile